-
12:00pm • Responding to Crises and Calls with Psychedelic Harm Reduction
-
12:15pm • A Fireside Chat with Rick Doblin and Christian Angermayer
-
12:15pm • Assessing the evidence for microdosing
-
12:30pm • Molecular and neuronal responses to psychedelic-induced plasticity
-
12:30pm • Amplifying the Wisdom of Psychedelic Elders
-
12:30pm • Addiction, family, plant medicine, and healing
-
2:30pm • Find the Others: How to Build Grassroots Psychedelic Communities
-
2:30pm • Psychohistoriographic approaches to Psychedelic Assisted Psychotherapy in Jamaica
-
2:30pm • A Life of Science and Dreams
-
2:30pm • Magnesium-Ibogaine: the Stanford Traumatic Injury to the CNS (MISTIC) Protocol – A Pilot Study in Special Operations Veterans with Traumatic Brain Injuries
-
2:30pm • Building momentum for new state policy approaches
-
2:30pm • Delivering patient-centered care in a profit-focused world
-
2:30pm • Educating the next generation of psychedelic practitioners
-
2:30pm • The Mazatec Sierra and the sacred mushrooms: Past and present
-
2:30pm • Psychedelic education today: kids, parents, and the public
-
2:30pm • Pilot study of Psilocybin-Assisted Therapy in Hospice care (PATH): preliminary feasibility, safety and efficacy considerations
-
2:45pm • Decolonization and the psychedelic renaissance
-
2:45pm • The Unified Field theory of Psychedelic Advocacy
-
2:45pm • Mechanisms and time-course of psilocybin-induced neuroplasticity in healthy human volunteers.
-
2:45pm • Preliminary results from a Pilot study of the efficacy and safety of ibogaine in the treatment of methadone detoxification
-
2:45pm • Educating the next generation of psychedelic practitioners
-
3:00pm • Regulatory considerations and opportunities
-
3:00pm • Psychedelics across intersectional diasporas
-
3:00pm • Session to be announced
-
3:00pm • A conversation with Amanda Feilding and Rick Doblin, Ph.D.
-
3:00pm • How To Change Your Mind: MDMA
-
3:00pm • The Impact of Psychedelic Drugs on Brain Function and Cognition
-
3:30pm • The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder
-
3:45pm • Psilocybin Mushrooms and their Tryptamines: Potential Medicines for Neurogeneration
-
3:45pm • Preparing for commercialization of psychedelic-assisted therapy
-
3:45pm • Iboga and Nagoya Protocols: Model for the Psychedelic Field
-
3:45pm • Navigating ethical considerations in psychedelic research and therapy
-
3:45pm • The neural basis of the acute effects of ayahuasca
-
3:45pm • A Family Legacy: From a Mother to her Sons
-
3:45pm • Psilocybin Therapy in Advanced Cancer
-
3:45pm • Increasing safety and participation in psychedelic research and communities among people of the global majority and gender/sexually expansive people
-
3:45pm • Safety and accountability in psychedelic communities
-
3:45pm • The Psychedelic Health Equity Initiative (PHEI)
-
3:45pm • Elephant in the Room? Safety and Abuse Liability in the Development of Psychedelic Drugs and Psychoactive Foods
-
4:08pm • The biological antidepressant effects of Ayahuasca
-
4:15pm • Managing hype, expectation, and risks in psychedelic therapy
-
4:15pm • Pragmatic Trial of Psilocybin Therapy in Palliative Care: A Multicenter Trial of Psilocybin Therapy for Demoralized Adults Near the End of Life
-
4:15pm • Swimming in the sacred: Wisdom from the psychedelic underground
-
4:15pm • Messages From the Underground and Other Elephants in the Room
-
4:30pm • The neuroscience of DMT: Past, present, and beyond
-
4:30pm • Rave as Ritual: The Intersection of Collective Movement and Entheogens
-
5:00pm • Building the next generation of psychedelic care clinics
-
5:00pm • Grof Legacy
-
5:15pm • Psychedelics in the Wild: Re-creating “Recreational”
-
5:15pm • Law enforcement, first responders, and drug policy reform
-
5:15pm • BIPOC Psychedelic Speed-Friending
-
5:15pm • Preparing for inspections of trial sites by the FDA
-
5:15pm • Appropriation, appreciation, and right relationship
-
5:15pm • Embedding Health Equity Principles into Psychedelic-Assisted Therapy and Education
-
5:15pm • Stealing Fire: How to Keep the Psychedelic Revolution Burning Brightly
-
5:15pm • Panel discussion on psilocybin therapy for cancer patients and palliative care
-
5:15pm • How Psychedelic Medicine Can Unlock Elite Performance
-
5:15pm • Sleep, Dreams, and Psychedelics
-
5:30pm • Building the next generation of psychedelic retreat centers
-
5:45pm • Cartography of the Soul: Artist Spotlight with 1OF1 and Christie's
-
5:45pm • Psilocybin-assisted therapy for frontline clinicians
-
5:45pm • Satire is sacred: the role of humor in keeping us “sane”
-
5:45pm • Mind-bending, mind–“mending”? The effect of psychedelics on flexible cognition, and underlying neural mechanisms
-
6:15pm • Welcome Reception in the Exhibition Hall
-
7:00pm • Peace of Mind
-
7:30pm • A Ceremony of the Psychedelic Story
-
7:50pm • Journey Through Nature
-
7:00am • 📊 Psychedelic Drug Pipeline Briefing Breakfast 📊
-
9:15am • Psychedelics: Spirituality, Mindfulness, and Mortality – Personal reflections and visions for the future
-
10:15am • Storytelling, grief, and liberation
-
10:15am • Opening address from John Mackey of Whole Foods
-
10:15am • The Potential of Psychedelic Therapies for Veterans and their Families
-
10:15am • The Opportunities and Challenges for New Psychedelic Researchers to Receive NIH Funding — Heffter Research Institute and International Society for Research on Psychedelics
-
10:15am • Psychedelics therapeutics: What we know, what we think, and what we need to research
-
10:15am • BioGnosis: Building Bridges: Connecting Science and Ancestral Wisdom
-
10:15am • “Show Me the Data” – Navigating Psychedelic Naysayers
-
10:15am • Religious Leaders / Psychedelic Access
-
10:15am • Psychedelics as The Great Disrupters: Reconstructing the Future of Mental Healthcare
-
10:15am • Effects of Psilocybin-Facilitated Experience on Religious Leaders: Quantitative and Qualitative Findings from the Johns Hopkins and NYU study
-
10:15am • Do's and Don'ts of Filing a RFRA Lawsuit - Religious Use Claims and Defenses
-
10:15am • Effects of Psilocybin in Alcohol Use Disorder: Beyond Reduction
-
10:30am • Pioneers of MDMA Therapy: Reflections on 20+ Years of MDMA Therapy and Research
-
10:30am • Lessons from the first three years of psychedelic public companies
-
10:30am • The State of Psychedelic Science Since 2017
-
10:45am • Exploring the Use of Human Brain Organoids to Study Psychedelics
-
10:45am • Psilocybin Treatment of Tobacco Addiction: From a Wing and a Prayer to Federally Funded Psychedelic Therapy Research
-
10:45am • New Federal Support for Research
-
10:45am • Intercultural entheogenic medicine in the treatment of addictions and other mental health challenges
-
10:45am • Healing, activism, and our precious earth
-
11:00am • A Table of Our Own
-
11:30am • Session to be announced
-
12:00pm • Ayahuasca-assisted addiction treatment in Peru: results, challenges, and promises from a multi-year, mixed-methods study at Takiwasi Center
-
12:00pm • The Story of Psychedelic Research for Veterans
-
12:00pm • Growing up: The next cycle of venture funding for psychedelic companies
-
12:00pm • Beyond symptom reduction: Lessons about the Nature of Healing
-
12:00pm • Naturalistic Psilocybin Use is Associated with Persisting Improvements in Mental Health and Well-being in a Large Prospective Sample
-
12:00pm • A Study of Oral Ibogaine in Opioid Withdrawal and Relapse Prevention
-
12:00pm • Confessions of the Psychedelic Elders
-
12:00pm • The Nature Medicine Health Act of Colorado: Progress For Who, How We Got Here, and Where We Go Next?
-
12:00pm • The promise of policy reform in Mexico
-
12:15pm • Reflections on a Lifetime with Psychedelics
-
12:15pm • Assessing Syncretic Ayahuasca Practices Globally: Results from a multi-site cohort study of ayahuasca drinkers in non-tribal contexts
-
12:30pm • Panel discussion and Q&A with addiction researchers
-
12:30pm • Investigating the health outcomes of ceremonial ayahuasca use in refugees and immigrants
-
12:30pm • Cat's Outta the Bag: How LSD Escaped into the General Public
-
12:30pm • Opportunities for Policy Reform in Canada
-
12:30pm • Trauma and psychedelic-assisted therapy
-
12:30pm • Psychedelic Training: Bridging Clinical Trials with Community Practice
-
12:30pm • Wellness and Psychedelics: Exploring the Data from 3000+ Individuals
-
12:45pm • Baseline predictors of acute ayahuasca effects among people attending ceremonial retreats in Costa Rica: A preliminary analysis from a longitudinal study
-
2:30pm • Building community-oriented therapy practices
-
2:30pm • Improving study design in trials using psychedelic-assisted therapies
-
2:30pm • Fostering Community Among Justice Impacted People
-
2:30pm • The Psychedelic Discovery Process
-
2:30pm • Innovations in Global Healthcare and Lessons for Psychedelics
-
2:30pm • Psilocybin-assisted Therapy for Major Depressive Disorder: Clinical Results and Cases From a Placebo-controlled, Fixed-order Trial
-
2:30pm • Veterans and the Journey of Plant Medicine
-
2:30pm • History and archeology of psilocybin mushrooms in Mesoamerica
-
2:30pm • Buddhism and Psychedelics
-
2:45pm • Tempering Psychedelics: A Conversation with Michael Pollan and Bob Jesse
-
2:45pm • Building community-oriented therapy practices
-
3:00pm • A conversation with Norma Lotsoff
-
3:00pm • Christianity and Psychedelics
-
3:00pm • Latest developments in Clinical studies for Depression
-
3:00pm • Session to be announced
-
3:00pm • Of Night and Light: The Story of Iboga and Ibogaine
-
3:00pm • Panel discussion on building community-oriented therapy practices
-
3:00pm • Alexander Shulgin Research Institute: Chemistry for Consciousness
-
3:45pm • The development of novel non-hallucinogenic drugs based on known psychedelics
-
3:45pm • Successful Protocol Designs for Psychedelic Clinical Trials – Use of Imaging, Biomarkers and Patient-Reported Outcomes
-
3:45pm • When psychedelic ritual migrates online
-
3:45pm • Trauma Support for the Families of Veterans
-
3:45pm • Islam and Psychedelics
-
3:45pm • Ketamine Treatment: Current Issues and Controversies
-
3:45pm • Indigenous Affinity: The Impacts of Legislation on Native Communities
-
3:45pm • Surviving NXIVM, cults, and sexual violence: A story of abuse, healing, and ketamine-assisted therapy retreats
-
3:45pm • What Psychedelics Can Teach Us About Love
-
3:45pm • The healthcare economics of psychedelic drugs and care
-
3:45pm • Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study
-
4:00pm • Panel discussion: The state of ketamine-assisted therapy
-
4:00pm • Functional Selectivity and Drug discovery for Novel Psychedelic Anti-Inflamamtories
-
4:00pm • Group administration and integration in psychedelic therapy
-
4:00pm • Achieving market access and reimbursement for psychedelic therapy
-
4:15pm • The mirror molecule: Ketamine as an addictive and anti-addictive, as poison and promise
-
4:15pm • Psychedelics and raising families
-
4:15pm • Supporting Veterans from Marginalized Communities
-
4:15pm • Panel discussion post-presentation
-
4:15pm • An old new dream: rebuilding society in the light of mystical insight
-
4:15pm • Judaism and Psychedelics
-
5:00pm • Session to be announced
-
5:15pm • Borderline Personality Disorder and the potential of psychedelic-assisted therapy
-
5:15pm • PTSD: The Other War Most Combat Veterans Fight: Psychedelics and Finally Coming Home
-
5:15pm • International psychedelic policy highlights
-
5:15pm • Psychedelics for First Responders: A Storytelling & Sharing Hour
-
5:15pm • MDMA-Assisted Therapy in The Treatment of Eating Disorders in Association With PTSD
-
5:15pm • Buddhism and Plant medicine; An Acceleration of Insight and Healing
-
5:15pm • Bridging traditional approaches with contemporary practice
-
5:15pm • The Canadian Psychedelic Survey; Results of a Large Cross-Sectional Survey of Canadian Adults Who Use Psychedelics
-
5:15pm • Efforts to Overcome New Drug Development Challenges
-
5:15pm • Building reciprocity in psychedelic companies
-
5:30pm • Effects of Psilocybin in Anorexia Nervosa
-
5:30pm • Mystical Crystals: The Chemistry of Psilocybin
-
5:45pm • Psychedelics & Psychosis: The Latest Science
-
5:45pm • Aligning purpose, profit, and public benefit in psychedelic businesses
-
5:45pm • Wonder and Healing at an Ayahuasca Centre, Peru
-
5:45pm • Psilocybin as a Treatment for Anorexia Nervosa (PANOREXIA): Pilot Study 6-Week Follow-Up Results
-
5:45pm • Considering psychedelic therapy for adolescents
-
5:45pm • Choreographing re-membrance: The Santo Daime bailado as danced epistemology
-
6:00pm • Family Matters in Psychedelic Therapy: Lessons Learned from a Psilocybin Trial for Anorexia Nervosa
-
6:00pm • Panel discussion on eating disorders
-
6:15pm • Networking Reception in Exhibition Hall
-
7:00pm • Psychedelic Revolution: The Secret History Of The LSD Trade
-
9:15am • A Message From The Amazon
-
10:15am • Phase 2 Multicenter Randomized Placebo-controlled, Double-blind Study to Assess Safety/Efficacy of Inhaled Cannabis in Veterans for PTSD
-
10:15am • From drug policy to public health and beyond
-
10:15am • An Overview of Current State Frameworks for Psychedelic Healing
-
10:15am • From personal to collective: ayahuasca as a peace-making tool among Palestinians and Israelis
-
10:15am • 5-MeO-DMT as a mental health tool: exploring possible mechanisms of action, the reactivation phenomenon, and some ethical considerations regarding the Sonoran Desert toad
-
10:15am • Asian Homecoming: A gathering for all Asians (East, West, South, Central, bicultural, diaspora)
-
10:15am • The Chapel of Sacred Mirrors
-
10:15am • Benefits of assessing biomarkers in psychedelic trials
-
10:15am • MDMA & Developmental Trauma: Transformation of Self-Awareness & Self-Compassion
-
10:15am • A randomized controlled trial of LSD-assisted psychotherapy to treat metastatic cancer induced bone pain
-
10:15am • Patents, commons, and innovation in psychedelic drug development
-
10:45am • From observational research to therapeutic applications: 5-MeO-DMT
-
10:45am • IFS as a Safe and Deep Healing Map to Psychedelic Territory
-
10:45am • Emerging research on psychedelic therapies for the treatment of pain
-
10:45am • Learnings, wisdom for therapists considering offering psychedelic-assisted therapy
-
11:00am • BioGnosis: Bridges to Ancestral Wisdom
-
12:00pm • Integrating Indigenous Wisdom into Psychedelic Therapy
-
12:00pm • Telemedicine models for supporting psychedelic therapy
-
12:00pm • Indigenous Uses of Psilocybin Mushrooms and Psychedelic Capitalism
-
12:00pm • Art Integration, Peer Support, and Veteran Healing Journeys
-
12:00pm • Sex and Psychedelics: Weaving Altered States for Healing and Pleasure
-
12:00pm • Begrijpt u nu waarom ik huil? (Now do you get it?)
-
12:00pm • Psychedelic-Assisted Training: Outcomes from a First-World Study
-
12:00pm • Critical perspectives on critical issues: IP
-
12:00pm • Regulating State Markets for Psychedelic-Assisted Services
-
12:00pm • Toward “next generation” ketamine treatment: from new insights into the neurobiology of depression to strategies to optimize ketamine efficacy
-
12:15pm • Plant medicine and reciprocity
-
12:15pm • Psychedelic drugs as a potential treatment for headache disorders
-
12:30pm • Spiritual Healing in Psychedelic Psychotherapy
-
12:30pm • Critical perspectives on critical issues: data and privacy
-
12:30pm • Breaking Patterns and Finding Meaning: A Study on Low-Dose LSD
-
12:30pm • A trial of ketamine masked by surgical anesthesia in depressed patients
-
12:30pm • New Directions for Psychedelic Therapies: Exploring Psilocybin in Alzheimer's Disease and Chronic Lyme Disease
-
12:30pm • Next generation assistive tech for psychedelic therapy
-
12:45pm • Grounding Psychedelic Research in Memory for Advancing Psychedelic Drug Discovery
-
12:45pm • Sergey Vardanyan + James Gordon MD
-
2:30pm • Beyond Ecstasy: Progress in Developing and Understanding a Novel Class of Therapeutic Medicine
-
2:30pm • Have a Safe Trip: Navigating the Complexities of Psychedelic Research and Harm Reduction
-
2:30pm • How to Get Involved and Participate in State Ecosystems
-
2:30pm • Magnesium-Ibogaine: the Stanford Traumatic Injury to the CNS (MISTIC) Protocol – A Pilot Study in Special Operations Veterans with Traumatic Brain Injuries
-
2:30pm • Climate, Biodiversity, and Plant Medicines
-
2:30pm • Psychedelic Outcomes: Intersection of Environment, Self-Identity, and Success ( The POIESIS Study)
-
2:30pm • Psychedelic therapy for depression: A DMT approach
-
2:30pm • Innovation, privacy, and data science in psychedelic therapy
-
2:30pm • Comparative Conspirituality: A Decolonial Approach From the Global South
-
2:30pm • The Responsibility of Psychedelic Journalism
-
2:30pm • Couples therapy and psychedelic-assisted therapy
-
2:45pm • Potentialities and Challenges of Ayahuasca in the Psychedelic Renaissance
-
2:45pm • Psychedelics as relational medicines: Investigating the role of psychosocial factors for outcomes of clinical and naturalistic psychedelic use
-
3:00pm • A conversation with Carl Hart, Ph.D.
-
3:00pm • Effects of psilocybin-assisted psychotherapy on personality and their relationship with self-compassion among individuals with alcohol use disorder
-
3:00pm • The Way of the Psychonaut: Stanislav Grof and the Journey of Consciousness
-
3:00pm • Safety, tolerability, and effects of vaporized DMT on cognition
-
3:00pm • The future of psychedelic manufacturing
-
3:15pm • Psychedelic Personality Change: Observations, Mechanisms, and Limitations
-
3:30pm • Psychedelics, addiction, and recovery
-
3:45pm • Mental well-being changes in older adults attending ceremonial psychedelic group sessions
-
3:45pm • An Overview of State Psychedelics Projects
-
3:45pm • Underground History and Overground Future
-
3:45pm • Queering Psychedelics
-
3:45pm • The War in Ukraine and Psychedelic-Assisted Therapy
-
3:45pm • Designing a post-prohibition future
-
3:45pm • So you want to be a psychedelic professional
-
4:00pm • The telescope of the mind: Can psychedelics provide insights into consciousness?
-
4:00pm • The Love Project: Preliminary outcomes of a survey study among psychedelic users
-
4:15pm • Transformational synergies: Together, MDMA and experiential-relational psychotherapeutic interventions can accelerate the healing of attachment trauma
-
4:15pm • Psychedelics and Sexual Functioning: a Mixed-Method Study in Healthy and Depressed Subjects
-
4:15pm • Female leadership in the psychedelic industry
-
4:15pm • Psychedelics and artificial intelligence
-
4:30pm • Psychedelics during the global crisis: 3 years of longitudinal assessments
-
5:00pm • Indigenous Perspectives on the Globalization of Ayahuasca
-
5:00pm • Lessons from the cannabis industry
-
5:00pm • A conversation with Ethan Nadelmann
-
5:00pm • Psychedelics, joy, and celebration
-
5:00pm • Unresolved Issues in the Psychedelics Community
-
5:15pm • Peyote History and Politics in Mexico
-
5:15pm • The Global Psychedelic Society: Resourcing, Connecting, & Supporting Psychedelic Community Worldwide
-
5:30pm • Dismantling the Myth of “Mother Ayahuasca”
-
5:30pm • Becoming a Psychedelic Therapist
